The immunotherapy candidate TNFSF4 may help the induction of a promising immunological response in breast carcinomas
Abstract Immune checkpoint blockade, an immunotherapy, has been applied in multiple systemic malignancies and has improved overall survival to a relatively great extent; whether it can be applied in breast cancer remains unknown. We endeavored to explore possible factors that may influence immunothe...
Guardado en:
Autores principales: | Kai Li, Lei Ma, Ye Sun, Xiang Li, Hong Ren, Shou-Ching Tang, Xin Sun |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bbf27ca926fd41d7b6bf1a3437ce9d68 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cancer immunology and immunotherapy
por: Xiubao Ren
Publicado: (2021) -
Deletion of a putative promoter-proximal Tnfsf11 regulatory region in mice does not alter bone mass or Tnfsf11 expression in vivo.
por: Ryan S MacLeod, et al.
Publicado: (2021) - Cancer immunology, immunotherapy
-
Dissecting Abdominal Aortic Aneurysm Is Aggravated by Genetic Inactivation of LIGHT (TNFSF14)
por: Andrea Herrero-Cervera, et al.
Publicado: (2021) -
Prognostic and Immunological Significance of CXCR2 in Ovarian Cancer: A Promising Target for Survival Outcome and Immunotherapeutic Response Assessment
por: Haizhou Ji, et al.
Publicado: (2021)